Teva submits NDA for ecopipam to treat pediatric Tourette syndrome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. WBD
4. AMC
5. NUAI
6. MSFT
7. ACN
8. AMZN
9. FFAI
10. PAA

Go back to Teva submits NDA for ecopipam to treat pediatric Tourette syndrome
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 39.06 +0.08 (0.21%)
Previous Close $38.98    52 Week High $66.55 
Open $39.09    52 Week Low $37.82 
Day High $39.09    P/E N/A 
Day Low $38.36    EPS $0.00 
Volume 431,394